Skip to main content
Premium Trial:

Request an Annual Quote

NIDA Seeks Recommendations on SNPs to Develop 'Neuroarray' Platform

NEW YORK (GenomeWeb News) - The National Institute of Drug Abuse is seeking nominations for SNPs to include in a custom microarray platform it is designing to study the genetics and pharmacogenetics of drug abuse, addiction, and related mental disorders.
 
In a request for information released on Friday, NIDA said that it plans to develop the so-called Neuroarray “pending availability of funds,” and that it is looking for community input on “custom SNPs that provide in-depth coverage of genes with prior knowledge of association with drug addiction and related disorders.”
 
NIDA said it intends to make the array available competitively “through standard NIH mechanisms” to help researchers study genetic vulnerability to addiction and related disorders, and to develop genetic patient profiles for targeted pharmacotherapies.
 
The deadline for responses is March 30. Nominations for SNPs can be submitted here.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.